SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Morgan Stanley Capital Trust III, 6 1/4% Capital Securities (MWR) trades at a trailing P/E of 2.5. Trailing earnings yield is 39.53%. PEG 0.09 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (2.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.09); earnings yield beats bond yields (39.53%).
- PEG Ratio 0.09 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 39.53% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MWR
Valuation Multiples
P/E (TTM)2.5
Forward P/EN/A
PEG Ratio0.09
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$10.21
Book Value / Share$0.00
Revenue / Share$3,806.47
FCF / Share$0.00
Yields & Fair Value
Earnings Yield39.53%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$0.52 |
$26.11B |
$993M |
3.8% |
| 2013 |
$1.45 |
$32.42B |
$2.83B |
8.7% |
| 2014 |
$1.91 |
$34.28B |
$3.77B |
11% |
| 2015 |
$2.10 |
$35.16B |
$4.1B |
11.6% |
| 2016 |
$1.80 |
$34.63B |
$3.4B |
9.8% |
| 2017 |
$1.14 |
$37.95B |
$2.07B |
5.4% |
| 2018 |
$3.76 |
$40.11B |
$6.54B |
16.3% |
| 2019 |
$5.63 |
$41.42B |
$9.24B |
22.3% |
| 2024 |
$7.95 |
$53.15B |
$13.53B |
25.5% |
| 2025 |
$10.21 |
$60.6B |
$17.03B |
28.1% |
